Studies revealed that omentin-1 enhances insulin-stimulated glucose uptake in vitro in both omental and subcutaneous adipocytes and its serum levels are reduced in patients with T2DM and glucose intolerance [6, 10]. The gene discussed is INS; the disease is Glucose intolerance.